Biểu đồ giá cổ phiếu BNTX
BNTX Dự đoán giá cổ phiếu
Biontech SE
$90.89
-1.44%
$-1.32
Khi đóng cửa: Jun 18, 16:00:00 GMT-4
$91.65
0.83%
$0.76
Phiên sau giờ: Jun 18, 20:00:00 GMT-4
Quay lại
Biontech SE (BNTX) Dự đoán giá cổ phiếu
Thống kê chính
Giá đóng cửa trước
$92.22
Giá mở cửa
$92.18
Phạm vi ngày
$90.12 - $93.13
Phạm vi 52 tuần
$79.52 - $124
Khối lượng
877.9K
Khối lượng trung bình
1.0M
Tỷ suất cổ tức
0.00%
EPS (TTM)
-5.70
Vốn hóa thị trường
$23.1B
BNTX là gì?
BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. The firm focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The firm is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. The company also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
